Correction to: Picking and Choosing Among Phase I Trials
Journal of Bioethical Inquiry 18 (1):193-193 (2021)
Abstract
The article "Picking and Choosing Among Phase I Trials", written by Jill A. Fisher, Torin Monahan and Rebecca L. Walker, was originally published Online First without Open Access. After publication in volume 16, issue 4, page 535-549 the author decided to opt for Open Choice and to make the article an Open Access publication.My notes
Similar books and articles
Picking and Choosing Among Phase I Trials: A Qualitative Examination of How Healthy Volunteers Understand Study Risks.Jill A. Fisher, Torin Monahan & Rebecca L. Walker - 2019 - Journal of Bioethical Inquiry 16 (4):535-549.
Picking and Choosing Among Phase I Trials: A Qualitative Examination of How Healthy Volunteers Understand Study Risks.Jill A. Fisher, Torin Monahan & Rebecca L. Walker - 2019 - Journal of Bioethical Inquiry 16 (4):535-549.
Picking and Choosing Among Phase I Trials: A Qualitative Examination of How Healthy Volunteers Understand Study Risks.Jill A. Fisher, Torin Monahan & Rebecca L. Walker - 2019 - Journal of Bioethical Inquiry 16 (4):535-549.
Picking and Choosing Among Phase I Trials: A Qualitative Examination of How Healthy Volunteers Understand Study Risks.Jill A. Fisher, Torin Monahan & Rebecca L. Walker - 2019 - Journal of Bioethical Inquiry 16 (4):535-549.
Selected Issues Related to the Conduct, Reporting, and Analysis of Phase I Trials.Marcelle Denise Winget - 1996 - Dissertation, The Johns Hopkins University
"My Body is One of the Best Commodities": Exploring the Ethics of Commodification in Phase I Healthy Volunteer Clinical Trials.Rebecca L. Walker & Jill A. Fisher - 2019 - Kennedy Institute of Ethics Journal 29 (4):305-331.
Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research.Rebecca L. Walker, Marci D. Cottingham & Jill A. Fisher - 2018 - Journal of Medicine and Philosophy 43 (1):83-114.
Deception in the Single-Blind Run-In Phase of Clinical Trials.Howard Mann - 2007 - IRB: Ethics & Human Research 29 (2).
The Risk-Escalation Model: A Principled Design Strategy for Early-Phase Trials.Spencer Phillips Hey & Jonathan Kimmelman - 2014 - Kennedy Institute of Ethics Journal 24 (2):121-139.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2014 - Bioethics 28 (3):138-146.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is it Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
Clinical trials and scid row: The ethics of phase 1 trials in the developing world.Jonathan Kimmelman - 2007 - Developing World Bioethics 7 (3):128-135.
Picking and Choosing.Edna Ullmann-Margalit & Sidney Morgenbesser - 1977 - Social Research: An International Quarterly 44 (4):757-785.
Analytics
Added to PP
2020-08-29
Downloads
9 (#937,492)
6 months
1 (#450,993)
2020-08-29
Downloads
9 (#937,492)
6 months
1 (#450,993)
Historical graph of downloads
